UC launches 'REVIVE' clinical trial to test treatment for abdominal injury
Researchers at the University of Cincinnati are launching a clinical study for ResQFoam™, a new device for the treatment of life-threatening internal bleeding in the abdomen. UC Medical Center is one of a handful of Level I Trauma Centers in the United States selected to participate in the multicenter study.
Related Stories
Collaboration over consultation
October 16, 2026
New University of Cincinnati research published in the journal Health Expectations found stroke survivors participating in rehab research desire an approach that prioritizes shared decision-making, peer relationships and a focus on what they can accomplish rather than their deficits.
UC Med Mentors welcomes 39 new mentees at match event
October 15, 2026
University of Cincinnati College of Medicine medical students matched with 39 Oyler School mentees at a UC Med Mentors match event, beginning four-year mentoring relationships.
More physical activity may mean slower Parkinson’s disease progression
October 15, 2026
National media including the Washington Post and U.S. News & World Report highlighted University of Cincinnati research that found higher levels of physical activity were associated with slower declines in thinking and memory as well as slower worsening of movement symptoms for people with Parkinson’s disease.